Literature DB >> 19706716

A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection.

Sara Gredmark-Russ1, Marisa K Isaacson, Lisa Kattenhorn, Evelyn J Cheung, Nicki Watson, Hidde L Ploegh.   

Abstract

Murine gammaherpesvirus 68 (MHV-68) contains a ubiquitin (Ub)-specific cysteine protease (USP) domain embedded within the large tegument protein ORF64, as do all other herpesviruses. The biological role of this protease is still unclear, but for the alphaherpesvirus Marek's disease virus, its USP is involved in T-cell lymphoma formation. We here study the role of the MHV-68 USP, encoded by ORF64. By constructing a mutant virus with a single cysteine-to-alanine replacement in the active site of ORF64, we demonstrate that the USP activity of ORF64 is abolished. The mutant virus replicates less efficiently in vitro, and plaque size is reduced compared to that of a revertant virus. Electron microscopy of infected cells did not reveal any obvious differences in virion morphogenesis or differences in egress for the mutant and revertant viruses. Intraperitoneal infection of C57/BL6 mice demonstrates that the mutant virus is generally cleared by day 7, indicating a role for the USP in the persistence of MHV-68 infection or efficient replication. However, the USP activity in MHV-68 is unlikely to be involved in the establishment of latency or reactivation, since we observed no significant difference in viral DNA genome copy number in the spleen or in the number of cells that reactivate MHV-68 from latency. Our results for MHV-68 ORF64 are consistent with an enzymatic function of the tegument protein that is beneficial to the virus during acute infection, particularly in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706716      PMCID: PMC2753118          DOI: 10.1128/JVI.01017-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.

Authors:  P G Stevenson; J S May; X G Smith; S Marques; H Adler; U H Koszinowski; J P Simas; S Efstathiou
Journal:  Nat Immunol       Date:  2002-07-08       Impact factor: 25.606

Review 2.  Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 3.  HAUSP/USP7 as an Epstein-Barr virus target.

Authors:  M N Holowaty; L Frappier
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

4.  The wood mouse is a natural host for Murid herpesvirus 4.

Authors:  Kim Blasdell; Christina McCracken; Andy Morris; Anthony A Nash; Mike Begon; Malcolm Bennett; James P Stewart
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

5.  Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

Authors:  Melissa N Holowaty; Mahel Zeghouf; Hong Wu; Judy Tellam; Vicki Athanasopoulos; Jack Greenblatt; Lori Frappier
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

Review 6.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Virological and pathological features of mice infected with murine gamma-herpesvirus 68.

Authors:  N P Sunil-Chandra; S Efstathiou; J Arno; A A Nash
Journal:  J Gen Virol       Date:  1992-09       Impact factor: 3.891

8.  Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.

Authors:  N P Sunil-Chandra; S Efstathiou; A A Nash
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

9.  Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus.

Authors:  Jason B Weinberg; Mary L Lutzke; Rosiane Alfinito; Rosemary Rochford
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

10.  Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection.

Authors:  Scott A Tibbetts; Joy Loh; Victor Van Berkel; James S McClellan; Meagan A Jacoby; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  21 in total

1.  Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites.

Authors:  Christopher B Whitehurst; Cyrus Vaziri; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2.

Authors:  M Bolstad; F Abaitua; C M Crump; P O'Hare
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

4.  ZAP inhibits murine gammaherpesvirus 68 ORF64 expression and is antagonized by RTA.

Authors:  Yifang Xuan; Danyang Gong; Jing Qi; Chuanhui Han; Hongyu Deng; Guangxia Gao
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

5.  The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.

Authors:  Ravindra Kumar; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection.

Authors:  Chenglong Sun; Stefan A Schattgen; Prapaporn Pisitkun; Joan P Jorgensen; Adam T Hilterbrand; Lucas J Wang; John A West; Kathrine Hansen; Kristy A Horan; Martin R Jakobsen; Peter O'Hare; Heiko Adler; Ren Sun; Hidde L Ploegh; Blossom Damania; Jason W Upton; Katherine A Fitzgerald; Søren R Paludan
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

7.  The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.

Authors:  Ossie F Dyson; Joseph S Pagano; Christopher B Whitehurst
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 8.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.

Authors:  Kevin Brulois; Jae U Jung
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

10.  Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3.

Authors:  Shuai Wang; Kezhen Wang; Jie Li; Chunfu Zheng
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.